KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Oct 2019
Historique:
received: 01 08 2019
revised: 20 09 2019
accepted: 30 09 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 11 2 2020
Statut: epublish

Résumé

Loss-of-function mutations of the gene encoding Krev interaction trapped protein 1 (KRIT1) are associated with the pathogenesis of Cerebral Cavernous Malformation (CCM), a major cerebrovascular disease characterized by abnormally enlarged and leaky capillaries and affecting 0.5% of the human population. However, growing evidence demonstrates that KRIT1 is implicated in the modulation of major redox-sensitive signaling pathways and mechanisms involved in adaptive responses to oxidative stress and inflammation, suggesting that its loss-of-function mutations may have pathological effects not limited to CCM disease. The aim of this study was to address whether KRIT1 loss-of-function predisposes to the development of pathological conditions associated with enhanced endothelial cell susceptibility to oxidative stress and inflammation, such as arterial endothelial dysfunction (ED) and atherosclerosis. Silencing of KRIT1 in human aortic endothelial cells (HAECs), coronary artery endothelial cells (HCAECs), and umbilical vein endothelial cells (HUVECs) resulted in increased expression of endothelial proinflammatory adhesion molecules vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) and in enhanced susceptibility to tumor necrosis factor alpha (TNF-α)-induced apoptosis. These effects were associated with a downregulation of Notch1 activation that could be rescued by antioxidant treatment, suggesting that they are consequent to altered intracellular redox homeostasis induced by KRIT1 loss-of-function. Furthermore, analysis of the aorta of heterozygous

Identifiants

pubmed: 31590384
pii: ijms20194930
doi: 10.3390/ijms20194930
pmc: PMC6801783
pii:
doi:

Substances chimiques

KRIT1 Protein 0
Krit1 protein, mouse 0
Receptor, Notch1 0
Tumor Necrosis Factor-alpha 0
Vascular Cell Adhesion Molecule-1 0
Intercellular Adhesion Molecule-1 126547-89-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Telethon
ID : GGP15219/Coordinator
Pays : Italy

Références

J Exp Med. 1993 May 1;177(5):1277-86
pubmed: 8386742
Nature. 2016 Apr 7;532(7597):122-6
pubmed: 27027284
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12640-5
pubmed: 20616044
Free Radic Biol Med. 2016 Feb;91:224-35
pubmed: 26721591
Biochem Biophys Res Commun. 2013 Aug 16;438(1):90-6
pubmed: 23872064
Biochem Pharmacol. 2010 Dec 15;80(12):2032-41
pubmed: 20643108
J Exp Med. 2015 Nov 16;212(12):2147-63
pubmed: 26552708
Free Radic Biol Med. 2016 Mar;92:100-109
pubmed: 26795600
Biol Open. 2014 Nov 28;3(12):1228-35
pubmed: 25432514
Stroke Res Treat. 2012;2012:362941
pubmed: 22550613
J Biol Chem. 2014 Nov 21;289(47):33054-65
pubmed: 25320085
Stroke. 2015 May;46(5):1337-43
pubmed: 25791711
Autophagy. 2016;12(2):424-5
pubmed: 26902587
J Hypertens. 2015 May;33(5):912-20
pubmed: 25715094
Eur Heart J. 2013 Aug;34(32):2504-9
pubmed: 22645188
J Exp Med. 2011 Aug 29;208(9):1835-47
pubmed: 21859843
Int J Cardiol Heart Vasc. 2018 Mar 20;19:1-2
pubmed: 29946555
J Atheroscler Thromb. 2010 Aug 31;17(8):796-804
pubmed: 20379054
Free Radic Biol Med. 2014 Mar;68:134-47
pubmed: 24291398
Nutrients. 2016 Dec 26;9(1):null
pubmed: 28035952
Curr Pharm Des. 2009;15(27):3108-15
pubmed: 19754385
J Steroid Biochem Mol Biol. 2019 May;189:87-100
pubmed: 30817989
J Exp Med. 2010 Apr 12;207(4):881-96
pubmed: 20308363
Sci Rep. 2017 Aug 15;7(1):8296
pubmed: 28811547
Nature. 2017 May 18;545(7654):305-310
pubmed: 28489816
Neurosurg Rev. 2016 Oct;39(4):581-9
pubmed: 26779617
Int J Biochem Cell Biol. 2016 Dec;81(Pt B):254-270
pubmed: 27639680
Curr Opin Lipidol. 2016 Oct;27(5):513-20
pubmed: 27454451
J Neurosurg Sci. 2015 Sep;59(3):201-9
pubmed: 25896717
J Biol Chem. 2017 Nov 3;292(44):18178-18191
pubmed: 28893903
Nutrients. 2018 Jun 13;10(6):null
pubmed: 29899272
Circ Res. 1999 Jul 23;85(2):199-207
pubmed: 10417402
JCI Insight. 2019 Feb 7;4(3):null
pubmed: 30728328
Mol Neurobiol. 2018 Apr;55(4):2869-2883
pubmed: 28455700
Data Brief. 2017 Dec 13;16:929-938
pubmed: 29511711
Rare Dis. 2016 Jan 25;4(1):e1142640
pubmed: 27141412
Oxid Med Cell Longev. 2018 Sep 19;2018:5042428
pubmed: 30327714
Mol Cell. 2013 Feb 21;49(4):719-29
pubmed: 23317506
J Cell Biol. 2007 Oct 22;179(2):247-54
pubmed: 17954608
J Physiol Pharmacol. 2018 Feb;69(1):35-52
pubmed: 29769419
J Clin Invest. 2011 May;121(5):1871-81
pubmed: 21490399
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):543-53
pubmed: 12615665
Life Sci. 2010 Jul 17;87(3-4):100-10
pubmed: 20553954
Eur J Nutr. 2017 Feb;56(1):151-160
pubmed: 26433940
J Atheroscler Thromb. 2005;12(5):260-7
pubmed: 16205022
Biomed Pharmacother. 2017 Feb;86:694-704
pubmed: 28039849
Antioxidants (Basel). 2019 Jan 17;8(1):null
pubmed: 30658464
J Cell Mol Med. 2013 Mar;17(3):407-18
pubmed: 23388056
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9114-9
pubmed: 8799163
Circulation. 2015 Jan 20;131(3):289-99
pubmed: 25486933
Nutrients. 2017 Mar 29;9(4):null
pubmed: 28353649
Free Radic Biol Med. 2018 Feb 1;115:202-218
pubmed: 29170092
Cardiovasc Diabetol. 2012 Jun 13;11:65
pubmed: 22694757
Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2258-65
pubmed: 18802018
Physiol Rev. 2010 Jan;90(1):23-46
pubmed: 20086073
Cell Immunol. 2014 Feb;287(2):129-35
pubmed: 24491913
Dev Cell. 2015 Jan 26;32(2):181-90
pubmed: 25625207
J Am Soc Nephrol. 2004 Aug;15(8):1983-92
pubmed: 15284284
PLoS One. 2012;7(9):e44705
pubmed: 22970292
Nat Genet. 2017 Sep;49(9):1385-1391
pubmed: 28714975
PLoS One. 2010 Jul 26;5(7):e11786
pubmed: 20668652
Front Cardiovasc Med. 2018 Nov 06;5:148
pubmed: 30460244
J Cell Sci. 2014 Feb 15;127(Pt 4):701-7
pubmed: 24481819
Circulation. 2007 Mar 13;115(10):1285-95
pubmed: 17353456
Curr Top Dev Biol. 2010;92:277-309
pubmed: 20816399
Biofactors. 2017 Jul 8;43(4):475-485
pubmed: 28419584
Curr Opin Hematol. 2018 May;25(3):212-218
pubmed: 29547401
EMBO Mol Med. 2015 Sep 28;7(11):1403-17
pubmed: 26417067
Neurobiol Dis. 2016 May;89:65-75
pubmed: 26851500
Circ Res. 2018 Feb 2;122(3):433-443
pubmed: 29212778
Nat Commun. 2017 Nov 20;8(1):1620
pubmed: 29158473
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2702-10
pubmed: 22922958
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9052-7
pubmed: 10922059
Oncogene. 2008 Aug 28;27(37):5019-32
pubmed: 18469855
Cell Mol Life Sci. 2014 May;71(10):1881-92
pubmed: 24287896
PLoS One. 2009 Dec 11;4(12):e8244
pubmed: 20011512
J Cell Sci. 2018 Aug 13;131(15):
pubmed: 30030370
Nat Med. 2009 Feb;15(2):177-84
pubmed: 19151728
J Clin Invest. 1993 Oct;92(4):1866-74
pubmed: 7691889
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6485-6491
pubmed: 30338818
Arterioscler Thromb Vasc Biol. 1999 May;19(5):1223-30
pubmed: 10323773
Development. 2004 Mar;131(6):1437-48
pubmed: 14993192
J Nutr Metab. 2015;2015:823081
pubmed: 26199742
Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2288-96
pubmed: 11031217
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
Nature. 2007 Feb 15;445(7129):776-80
pubmed: 17259973
J Cell Biol. 2013 Aug 5;202(3):545-61
pubmed: 23918940
Exp Mol Med. 2015 Feb 06;47:e138
pubmed: 25656948
Nat Rev Mol Cell Biol. 2006 Sep;7(9):678-89
pubmed: 16921404

Auteurs

Francesco Vieceli Dalla Sega (F)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. vclfnc@unife.it.

Raffaella Mastrocola (R)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. raffaella.mastrocola@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. raffaella.mastrocola@unito.it.

Giorgio Aquila (G)

Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy. qlagrg@unife.it.

Francesca Fortini (F)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. frtfnc@unife.it.

Claudia Fornelli (C)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. claudia.fornelli@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. claudia.fornelli@unito.it.

Alessia Zotta (A)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessia.zotta@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessia.zotta@unito.it.

Alessia S Cento (AS)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessiasofia.cento@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessiasofia.cento@unito.it.

Andrea Perrelli (A)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. andrea.perrelli@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. andrea.perrelli@unito.it.

Enrica Boda (E)

CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. enrica.boda@unito.it.
Department of Neuroscience Rita Levi-Montalcini, Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Torino, 10043 Orbassano (TO), Italy. enrica.boda@unito.it.

Antonio Pannuti (A)

University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96822, USA. apannut@mac.com.

Saverio Marchi (S)

CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. s.marchi@univpm.it.
Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy. s.marchi@univpm.it.
Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy. s.marchi@univpm.it.

Paolo Pinton (P)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. pnp@unife.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. pnp@unife.it.
Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy. pnp@unife.it.

Roberto Ferrari (R)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. fri@unife.it.

Paola Rizzo (P)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. francesco.retta@unito.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. francesco.retta@unito.it.
Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy. francesco.retta@unito.it.

Saverio Francesco Retta (SF)

Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. rzzpla@unife.it.
CCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. rzzpla@unife.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH